A B S T R A C T
Sleep apnoea is associated with increased cardiovascular risk. Sleep apnoea is common after stroke and associated with increased blood pressure variability as described by Turkington and co-workers in this issue of Clinical Science. Both sleep apnoea and blood pressure variability confer a poor prognosis after stroke and are potentially treatable. Many studies of CPAP (continuous positive airway pressure) demonstrate decreases in cardiovascular risk markers in other patient groups. Although difficult to apply in these patients in the short term, CPAP has some potential benefits in mediumterm rehabilitation and secondary prevention following stroke, which warrants further study.
Stroke is common, with an incidence of 2-18/1000 per year, and is the most common cause for neurological admission to hospital, and accounts for a large burden of community disability [1] . Sleep disordered breathing has been recognized in stroke since the early 19th century [2] , but recent studies suggest a very high prevalence (> 50 %) of sleep apnoea after stroke compared with control groups [3, 4] , although there may be no increased risk after TIA (transient ischaemic attack) [5] . Central, as opposed to obstructive, apnoea may be more common after infratentorial stroke [6] , although both can occur in the same individual and neither predicts ischaemic or haemorrhagic subtypes nor neurological location [7] . The prevalence of sleep apnoea is highest early following stroke and may fall during recovery [8] . This reflects a decrease in sleep apnoea in most patients, but also hides a higher mortality in those with more severe sleep disordered breathing. In addition to increased mortality, sleep apnoea following stroke predicts worse stroke scores, cognitive deficits, disability, length of hospital stay and long-term functional outcome [9] [10] [11] [12] .
So, if stroke causes sleep apnoea, does sleep apnoea cause stroke? Since sleep apnoea is so common [13] it may, by chance, occur with stroke. However, work to date linking sleep apnoea and stroke includes only small numbers of subjects with sleep apnoea. These report relative risk for stroke of approx. 2-3 in self-reported habitual snorers (a weak surrogate for sleep apnoea) [14, 15] , and of approx. 5-8 in subjects with obstructive sleep apnoea.
Sleep apnoea may cause cardiovascular disease at various levels, for example, by causing known risk factors (hypertension or insulin resistance) or multiplying the effects of these known intermediary risk factors (through hypoxia or sympathetic activation), by initiating critical events (plaque rupture and thrombosis) or by increasing injury at the time of event or impairing subsequent repair processes (apnoea and hypoxia lower baroreflex sensitivity and increase sympathetic activation causing raised and variable blood pressure with platelet activation and endothelial damage extending thrombosis and ischaemic territory). Which of these precise mechanisms is involved is not yet clear, but recent studies at the cellular and molecular level have demonstrated many physiologically plausible mediators between sleep apnoea and vascular damage, including stroke [16] . Thus there are several mechanisms to explain the poorer prognosis in stroke patients with sleep apnoea, although other factors may also be important. Upper airway obstruction, for example, suggests bulbar or pseudobulbar dysfunction, and may precipitate aspiration of pharyngeal contents.
In this issue of Clinical Science, Turkington et al. [17] report increased blood pressure and blood pressure variability post stroke compared with controls, increased blood pressure variability in stroke with upper airways obstruction (respiratory disturbance index > 10/h) and strong positive association between upper airway obstruction and blood pressure variability. Both high blood pressure and variability are associated with poor outcome following stroke and this study [17] therefore suggests one intermediary between sleep apnoea and poor prognosis.
In the report by Turkington et al. [17] , blood pressure variability is raised in all patients post stroke compared with controls. Blood pressure variability may be raised by altered sleep-wake cycles, arousals Comment through noise or nursing procedures, or by central dysautonomia and altered chemo-and baro-reflexes. Despite all these potential confounders, the authors [17] report a really quite close relationship between blood pressure variability and sleep apnoea severity assessed by respiratory disturbance index (r = 0.642 compared with 10 mmHg dips). This is similar to the blood pressure fluctuations entrained in subjects with isolated sleep apnoea. The authors [17] also demonstrate deeper and longer falls in oxygen saturation during the studies in patients with upper airway obstruction. Cerebral blood flow autoregulation is disrupted following stroke and perfusion pressure may fall during episodes of sleep apnoea. It is mooted that the blood pressure dips reported here [17] could extend areas of critical ischaemia, especially in conjunction with apnoea-associated hypoxia and hypercapnia.
Our main aims of stroke treatment are to reduce mortality and disability. Recent advances have been made with thrombolytic treatment and there is convincing evidence for several drugs in primary and secondary prevention. Conversely, tight blood pressure control acutely following stroke and prevention of hypoxaemia with oxygen therapy have been disappointing. Upper airway obstruction presents a potential therapeutic target to improve outcomes, as control of sleep apnoea may prevent both hypoxaemia, large fluctuations in blood pressure and cerebral hypoperfusion. There are some theoretical benefits for protection of cerebral blood flow following stroke by the slight rise in CO 2 which occurs with hypoventilation. And concerns are expressed that supportive CPAP (continuous positive airway pressure) treatment or non-invasive ventilation may lower CO 2 and worsen outcomes. The few studies of CPAP so far have focused in the early post-stroke period and show blood pressure decreases, improved 'wellbeing', decreased depression at 1 month, but no change in activities of daily living or mortality [11, 18] . These studies are beset with problems of poor machine compliance, nursing time and consent issues.
In summary, sleep apnoea is associated with increased cardiovascular risk. Ongoing population studies are due to report soon on the incidence of stroke and ischaemic heart disease according to sleep apnoea severity and may confirm a relationship. Sleep apnoea is common after stroke and associated with increased blood pressure variability as described by Turkington et al. [17] in this issue of Clinical Science. Both sleep apnoea and blood pressure variability confer a poor prognosis after stroke and are potentially treatable. Many studies of CPAP demonstrate decreases in cardiovascular risk markers in other patient groups. Although difficult to apply in these patients in the short term, CPAP has some potential benefits in medium-term rehabilitation and secondary prevention following stroke which warrants further study.
